RedHill Biopharma Ltd. RDHL
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.05M | -3.05M | -- | -- | -2.07M |
| Total Depreciation and Amortization | 70.50K | 70.50K | -- | -- | 84.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.58M | 1.58M | -- | -- | 648.50K |
| Change in Net Operating Assets | -533.00K | -533.00K | -- | -- | -311.00K |
| Cash from Operations | -1.93M | -1.93M | -- | -- | -1.65M |
| Capital Expenditure | -7.00K | -7.00K | -- | -- | -2.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 193.00K | 193.00K | -- | -- | -- |
| Cash from Investing | 186.00K | 186.00K | -- | -- | -2.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -40.50K | -40.50K | -- | -- | -94.50K |
| Issuance of Common Stock | 2.73M | 2.73M | -- | -- | 1.72M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.69M | 2.69M | -- | -- | 1.63M |
| Foreign Exchange rate Adjustments | -500.00 | -500.00 | -- | -- | 4.50K |
| Miscellaneous Cash Flow Adjustments | -349.50K | -349.50K | -- | -- | -862.50K |
| Net Change in Cash | 594.00K | 594.00K | -- | -- | -875.50K |